These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7840078)

  • 1. Diets containing soluble oat extracts improve glucose and insulin responses of moderately hypercholesterolemic men and women.
    Hallfrisch J; Scholfield DJ; Behall KM
    Am J Clin Nutr; 1995 Feb; 61(2):379-84. PubMed ID: 7840078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of beta-glucan level in oat fiber extracts on blood lipids in men and women.
    Behall KM; Scholfield DJ; Hallfrisch J
    J Am Coll Nutr; 1997 Feb; 16(1):46-51. PubMed ID: 9013433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum lipids and postprandial glucose and insulin levels in hyperlipidemic subjects after consumption of an oat beta-glucan-containing ready meal.
    Biörklund M; Holm J; Onning G
    Ann Nutr Metab; 2008; 52(2):83-90. PubMed ID: 18334815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oat beta-glucan reduces blood cholesterol concentration in hypercholesterolemic subjects.
    Braaten JT; Wood PJ; Scott FW; Wolynetz MS; Lowe MK; Bradley-White P; Collins MW
    Eur J Clin Nutr; 1994 Jul; 48(7):465-74. PubMed ID: 7956987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breath hydrogen and methane expiration in men and women after oat extract consumption.
    Behall KM; Scholfield DJ; van der Sluijs AM; Hallfrisch J
    J Nutr; 1998 Jan; 128(1):79-84. PubMed ID: 9430606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol-lowering effect of beta-glucan from oat bran in mildly hypercholesterolemic subjects may decrease when beta-glucan is incorporated into bread and cookies.
    Kerckhoffs DA; Hornstra G; Mensink RP
    Am J Clin Nutr; 2003 Aug; 78(2):221-7. PubMed ID: 12885701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oat bran concentrate bread products improve long-term control of diabetes: a pilot study.
    Pick ME; Hawrysh ZJ; Gee MI; Toth E; Garg ML; Hardin RT
    J Am Diet Assoc; 1996 Dec; 96(12):1254-61. PubMed ID: 8948386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Food products containing free tall oil-based phytosterols and oat beta-glucan lower serum total and LDL cholesterol in hypercholesterolemic adults.
    Maki KC; Shinnick F; Seeley MA; Veith PE; Quinn LC; Hallissey PJ; Temer A; Davidson MH
    J Nutr; 2003 Mar; 133(3):808-13. PubMed ID: 12612157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled study on the effect of beta-glucan-rich oat bran on serum lipids in hypercholesterolemic subjects: relation to apolipoprotein E phenotype.
    Uusitupa MI; Ruuskanen E; Mäkinen E; Laitinen J; Toskala E; Kervinen K; Kesäniemi YA
    J Am Coll Nutr; 1992 Dec; 11(6):651-9. PubMed ID: 1334101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yeast-leavened oat breads with high or low molecular weight beta-glucan do not differ in their effects on blood concentrations of lipids, insulin, or glucose in humans.
    Frank J; Sundberg B; Kamal-Eldin A; Vessby B; Aman P
    J Nutr; 2004 Jun; 134(6):1384-8. PubMed ID: 15173400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentrated oat beta-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial.
    Queenan KM; Stewart ML; Smith KN; Thomas W; Fulcher RG; Slavin JL
    Nutr J; 2007 Mar; 6():6. PubMed ID: 17386092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of high-amylose starch and oat bran on metabolic variables and bowel function in subjects with hypertriglyceridemia.
    Noakes M; Clifton PM; Nestel PJ; Le Leu R; McIntosh G
    Am J Clin Nutr; 1996 Dec; 64(6):944-51. PubMed ID: 8942421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in serum lipids and postprandial glucose and insulin concentrations after consumption of beverages with beta-glucans from oats or barley: a randomised dose-controlled trial.
    Biörklund M; van Rees A; Mensink RP; Onning G
    Eur J Clin Nutr; 2005 Nov; 59(11):1272-81. PubMed ID: 16015250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oat β-glucan: physico-chemical characteristics in relation to its blood-glucose and cholesterol-lowering properties.
    Wang Q; Ellis PR
    Br J Nutr; 2014 Oct; 112 Suppl 2():S4-S13. PubMed ID: 25267243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of hormone and glucose responses of overweight women to barley and oats.
    Behall KM; Scholfield DJ; Hallfrisch J
    J Am Coll Nutr; 2005 Jun; 24(3):182-8. PubMed ID: 15930484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-glucan fractions from barley and oats are similarly antiatherogenic in hypercholesterolemic Syrian golden hamsters.
    Delaney B; Nicolosi RJ; Wilson TA; Carlson T; Frazer S; Zheng GH; Hess R; Ostergren K; Haworth J; Knutson N
    J Nutr; 2003 Feb; 133(2):468-75. PubMed ID: 12566485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 6 weeks' consumption of β-glucan-rich oat products on cholesterol levels in mildly hypercholesterolaemic overweight adults.
    Charlton KE; Tapsell LC; Batterham MJ; O'Shea J; Thorne R; Beck E; Tosh SM
    Br J Nutr; 2012 Apr; 107(7):1037-47. PubMed ID: 21810288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Food labeling: health claims; soluble dietary fiber from certain foods and coronary heart disease. Interim final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Oct; 67(191):61773-83. PubMed ID: 12361061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barley and wheat foods: influence on plasma cholesterol concentrations in hypercholesterolemic men.
    McIntosh GH; Whyte J; McArthur R; Nestel PJ
    Am J Clin Nutr; 1991 May; 53(5):1205-9. PubMed ID: 1850576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oat-derived beta-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia.
    Reyna-Villasmil N; Bermúdez-Pirela V; Mengual-Moreno E; Arias N; Cano-Ponce C; Leal-Gonzalez E; Souki A; Inglett GE; Israili ZH; Hernández-Hernández R; Valasco M; Arraiz N
    Am J Ther; 2007; 14(2):203-12. PubMed ID: 17414591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.